Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pseudomyxoma Peritonei × Bromelains × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1 Neoplasms, Cystic, Mucinous, and Serous 1 Neoplasms 1 Adenocarcinoma, Mucinous 1

Interventions

Mitomycin 2 Capecitabine 2 Tacrolimus 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Lansoprazole 1 Ipilimumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Clarithromycin 1 CTLA-4 Antigen 1 Bromelains 1 Amoxicillin 1 Alemtuzumab 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Mucpharm Pty Ltd

Phase 2 Unknown

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡